VRTX Insider Transactions — Page 6
3,822 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 501–600; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Lee Yuchun | Director | 2022-04-12 | Sale | 1,182.0 | $280.61 |
| Lee Yuchun | Director | 2022-04-12 | Sale | 200.0 | $279.22 |
| Lee Yuchun | Director | 2022-04-11 | Sale | 110.0 | $281.58 |
| Lee Yuchun | Director | 2022-04-11 | Sale | 968.0 | $280.62 |
| Lee Yuchun | Director | 2022-04-11 | Sale | 922.0 | $279.81 |
| Lee Yuchun | Director | 2022-04-08 | Sale | 452.0 | $280.37 |
| Lee Yuchun | Director | 2022-04-08 | Sale | 700.0 | $279.36 |
| Lee Yuchun | Director | 2022-04-08 | Sale | 430.0 | $277.29 |
| Lee Yuchun | Director | 2022-04-08 | Sale | 418.0 | $276.62 |
| Bhatia Sangeeta N. | Director | 2022-04-08 | Sale | 1,907.0 | $280.2 |
| MCGLYNN MARGARET G | Director | 2022-04-08 | Sale | 100.0 | $281.49 |
| MCGLYNN MARGARET G | Director | 2022-04-08 | Sale | 4,900.0 | $280.19 |
| Lee Yuchun | Director | 2022-04-07 | Sale | 100.0 | $277.02 |
| Lee Yuchun | Director | 2022-04-07 | Sale | 727.0 | $276.37 |
| Lee Yuchun | Director | 2022-04-07 | Sale | 256.0 | $275.26 |
| Lee Yuchun | Director | 2022-04-07 | Sale | 500.0 | $273.78 |
| Lee Yuchun | Director | 2022-04-07 | Sale | 417.0 | $272.76 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-04-07 | Sale | 30.0 | $277.02 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-04-07 | Sale | 327.0 | $276.39 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-04-07 | Sale | 204.0 | $275.71 |
| Lee Yuchun | Director | 2022-04-06 | Sale | 83.0 | $272.84 |
| Lee Yuchun | Director | 2022-04-06 | Sale | 1,600.0 | $271.78 |
| Lee Yuchun | Director | 2022-04-06 | Sale | 300.0 | $270.67 |
| Lee Yuchun | Director | 2022-04-06 | Sale | 17.0 | $267.57 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-04-05 | Sale | 3,163.0 | $275.23 |
| Lee Yuchun | Director | 2022-04-05 | Sale | 461.0 | $274.66 |
| Lee Yuchun | Director | 2022-04-05 | Sale | 100.0 | $273.5 |
| Lee Yuchun | Director | 2022-04-05 | Sale | 600.0 | $272.6 |
| Lee Yuchun | Director | 2022-04-05 | Sale | 488.0 | $271.94 |
| Lee Yuchun | Director | 2022-04-05 | Sale | 334.0 | $270.05 |
| Lee Yuchun | Director | 2022-04-05 | Sale | 17.0 | $268.3 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-04-04 | Sale | 257.0 | $268.43 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-04-04 | Sale | 305.0 | $267.1 |
| Lee Yuchun | Director | 2022-04-04 | Sale | 983.0 | $268.36 |
| Lee Yuchun | Director | 2022-04-04 | Sale | 917.0 | $267.23 |
| Lee Yuchun | Director | 2022-04-04 | Sale | 100.0 | $265.83 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2022-04-01 | Sale | 223.0 | $266.68 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2022-04-01 | Sale | 536.0 | $265.95 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2022-04-01 | Sale | 1,142.0 | $265.06 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2022-04-01 | Sale | 381.0 | $263.67 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2022-04-01 | Sale | 300.0 | $261.42 |
| MCGLYNN MARGARET G | Director | 2022-03-31 | Sale | 1,011.0 | $262.97 |
| MCGLYNN MARGARET G | Director | 2022-03-31 | Sale | 2,970.0 | $262.37 |
| MCGLYNN MARGARET G | Director | 2022-03-31 | Sale | 1,019.0 | $261.28 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-03-17 | Sale | 34.0 | $251.24 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-03-17 | Sale | 2,799.0 | $250.1 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2022-03-17 | Sale | 61.0 | $251.05 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2022-03-17 | Sale | 3,110.0 | $250.13 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-03-17 | Sale | 2,122.0 | $250.06 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-25 | Sale | 18.0 | $232.8 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-25 | Sale | 87.0 | $231.81 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-25 | Sale | 115.0 | $230.97 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-25 | Sale | 77.0 | $230.26 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-25 | Sale | 28.0 | $228.88 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-25 | Sale | 560.0 | $232.68 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-25 | Sale | 2,784.0 | $231.64 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-25 | Sale | 3,188.0 | $230.62 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-25 | Sale | 1,040.0 | $229.41 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-18 | Sale | 120.0 | $233.48 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-18 | Sale | 80.0 | $232.04 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-18 | Sale | 101.0 | $230.42 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-18 | Sale | 218.0 | $229.52 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-18 | Sale | 1,038.0 | $233.27 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-18 | Sale | 600.0 | $231.85 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-18 | Sale | 385.0 | $231.01 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-18 | Sale | 1,303.0 | $230.05 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-18 | Sale | 986.0 | $229.22 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-14 | Sale | 2,444.0 | $232.02 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-11 | Sale | 42.0 | $236.85 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-11 | Sale | 70.0 | $235.87 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-11 | Sale | 78.0 | $234.93 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2022-02-11 | Sale | 100.0 | $233.92 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-11 | Sale | 98.0 | $237.23 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-11 | Sale | 601.0 | $236.28 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-11 | Sale | 757.0 | $234.95 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-11 | Sale | 841.0 | $233.92 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2022-02-02 | Sale | 2,944.0 | $250.07 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-02-02 | Sale | 16.0 | $254.54 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-02-02 | Sale | 64.0 | $253.95 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-02-02 | Sale | 149.0 | $253.07 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-02-02 | Sale | 141.0 | $251.47 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2022-02-02 | Sale | 670.0 | $250.04 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-02 | Sale | 300.0 | $254.46 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-02 | Sale | 1,099.0 | $253.41 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-02 | Sale | 900.0 | $252.1 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-02 | Sale | 980.0 | $251.22 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-02 | Sale | 754.0 | $249.97 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-02 | Sale | 127.0 | $248.65 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2022-02-02 | Sale | 500.0 | $247.73 |
| MCGLYNN MARGARET G | Director | 2022-01-28 | Sale | 212.0 | $243.24 |
| MCGLYNN MARGARET G | Director | 2022-01-28 | Sale | 2,087.0 | $242.78 |
| MCGLYNN MARGARET G | Director | 2022-01-28 | Sale | 800.0 | $241.83 |
| MCGLYNN MARGARET G | Director | 2022-01-28 | Sale | 1,901.0 | $240.53 |
| Sachdev Amit | EVP, Chief Patient Officer | 2021-11-15 | Sale | 30.0 | $187.48 |
| Sachdev Amit | EVP, Chief Patient Officer | 2021-11-15 | Sale | 21.0 | $186.78 |
| Arbuckle Stuart A | EVP, COO | 2021-11-15 | Sale | 1.0 | $187.8 |
| Arbuckle Stuart A | EVP, COO | 2021-11-15 | Sale | 2.0 | $186.99 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2021-11-15 | Sale | 20.0 | $187.51 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2021-11-15 | Sale | 14.0 | $186.8 |
| Kewalramani Reshma | CEO & President | 2021-08-19 | Purchase | 4,243.0 | $196.34 |